Clarius Ultrasound Scanner
Clarius Mobile Health Corp. • Radiology • 08/29/2019
Device Purpose
The Clarius Ultrasound Scanner is a portable diagnostic imaging system designed for broad clinical utility, leveraging wireless transducer technology and software on mobile devices to provide real-time ultrasound and fluid flow analysis. Its methodology centers on offering diverse imaging modes and specialized features like needle enhancement across multiple transducer types, aiming to deliver accessible, high-resolution imaging for trained healthcare professionals in various medical environments.
Summary
The Clarius Ultrasound Scanner is a portable, software-controlled diagnostic ultrasound system designed to acquire and display high-resolution, real-time ultrasound data. It utilizes wireless transducers that communicate via Bluetooth and Wi-Fi with standard iOS or Android smartphones and tablets, enabling users to view and export images on these portable devices. The system comprises various transducer models, including Convex Array, Linear Array, Phased Array, and Intracavity types, along with newer HD models, catering to a wide range of imaging needs through its dedicated Clarius Ultrasound App. Intended for use by trained medical professionals in diverse healthcare settings, including emergency medical services, the Clarius Ultrasound Scanner supports numerous clinical applications such as ophthalmic, fetal, abdominal, cardiac, musculoskeletal, and vascular imaging, among many others. It also facilitates procedural guidance of needles into the body. The system offers multiple imaging modes including B-mode, M-mode, Color Doppler, Power Doppler, and Pulsed Wave Doppler (PWD), along with combined modes (e.g., B+M, B+CD) and a needle enhancement feature in B-Mode for specific applications noted across its various scanner models.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. What are the specific image quality differences and diagnostic advantages observed between the new HD transducer models (e.g., L15 HD, PA HD) and the previous non-HD models across various clinical applications like musculoskeletal or peripheral vessel imaging?; How does the system's performance, particularly wireless connectivity stability and battery life, hold up under demanding real-world conditions such as in an emergency medical services (EMS) environment or during prolonged intra-operative use?; Are there quantitative data comparing the 'Needle Enhancement in B-Mode' feature across different Clarius scanner models and its impact on procedural accuracy and time in clinical practice?; Given the reliance on off-the-shelf (OTS) iOS or Android devices, what are the minimum device specifications required for optimal performance of the Clarius App, and how does the system manage data security and patient privacy on these consumer devices?; For the wide range of indicated uses, such as fetal or cardiac imaging, what specific training protocols or proficiency benchmarks are recommended for clinicians to ensure effective and safe utilization of the Clarius Ultrasound Scanner, especially for those transitioning from traditional cart-based systems?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Authorized before §524B enforcement
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of SaaSBOM, OBOM detected in AI-generated device summary.
• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.
• Not detected in AI-generated device summary: SBOM, ML-BOM, HBOM, CBOM, VDR/VEX. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly